1. Home
  2. DLX vs FTRE Comparison

DLX vs FTRE Comparison

Compare DLX & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLX
  • FTRE
  • Stock Information
  • Founded
  • DLX 1915
  • FTRE 1996
  • Country
  • DLX United States
  • FTRE United States
  • Employees
  • DLX N/A
  • FTRE N/A
  • Industry
  • DLX Advertising
  • FTRE Medical Specialities
  • Sector
  • DLX Consumer Discretionary
  • FTRE Health Care
  • Exchange
  • DLX Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • DLX 867.6M
  • FTRE 864.4M
  • IPO Year
  • DLX N/A
  • FTRE N/A
  • Fundamental
  • Price
  • DLX $18.75
  • FTRE $10.03
  • Analyst Decision
  • DLX Strong Buy
  • FTRE Hold
  • Analyst Count
  • DLX 1
  • FTRE 8
  • Target Price
  • DLX $23.00
  • FTRE $11.64
  • AVG Volume (30 Days)
  • DLX 340.4K
  • FTRE 1.3M
  • Earning Date
  • DLX 11-05-2025
  • FTRE 11-05-2025
  • Dividend Yield
  • DLX 6.40%
  • FTRE N/A
  • EPS Growth
  • DLX 47.66
  • FTRE N/A
  • EPS
  • DLX 1.83
  • FTRE N/A
  • Revenue
  • DLX $2,118,526,000.00
  • FTRE $2,759,900,000.00
  • Revenue This Year
  • DLX $0.20
  • FTRE $0.47
  • Revenue Next Year
  • DLX $1.65
  • FTRE N/A
  • P/E Ratio
  • DLX $10.26
  • FTRE N/A
  • Revenue Growth
  • DLX N/A
  • FTRE 1.88
  • 52 Week Low
  • DLX $13.61
  • FTRE $3.97
  • 52 Week High
  • DLX $24.30
  • FTRE $25.05
  • Technical
  • Relative Strength Index (RSI)
  • DLX 43.17
  • FTRE 47.42
  • Support Level
  • DLX $17.76
  • FTRE $9.60
  • Resistance Level
  • DLX $21.11
  • FTRE $12.07
  • Average True Range (ATR)
  • DLX 0.71
  • FTRE 0.99
  • MACD
  • DLX -0.09
  • FTRE -0.16
  • Stochastic Oscillator
  • DLX 19.61
  • FTRE 16.62

About DLX Deluxe Corporation

Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: